Logo
x

Search

Subscribe Now

Vanda Pharmaceuticals

The US FDA Approves Vanda Pharmaceuticals' Fanapt for Treating Bipolar I Disorder

The US FDA Approves Vanda Pharmaceuticals' Fanapt for Treating Bipolar I Disorder

  • April 3, 2024
Vanda Pharmaceuticals to Acquire the US and Canadian Rights for Ponvory from Actelion to Treat Relapsing Multiple Sclerosis

Vanda Pharmaceuticals to Acquire the US and Canadian Rights for Ponvory from Actelion to Treat Relapsing Multiple Sclerosis

  • December 8, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.